Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.185
-0.055 (-4.44%)
At close: Jul 17, 2026, 4:00 PM EDT
1.220
+0.035 (2.95%)
After-hours: Jul 17, 2026, 7:55 PM EDT
Milestone Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Milestone Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $6.33. The average 1-year stock price forecast is 434.18% higher than the current stock price, while the lowest is $2.00 (+68.78%) and the highest is $8.00 (+575.11%).
Price Target: $6.33 (+434.18%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on May 26, 2026.
Analyst Ratings
The average analyst rating for Milestone Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $8 | Buy | Maintains | $8 | +575.11% | May 26, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $7 | Buy | Reiterates | $7 | +490.72% | May 14, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $8 | Buy | Maintains | $8 | +575.11% | May 13, 2026 |
| Raymond James | Raymond James | Buy Initiates $6 | Buy | Initiates | $6 | +406.33% | Apr 9, 2026 |
Financial Forecast
Revenue This Year
7.14M
from 1.55M
Increased by 362.08%
Revenue Next Year
29.53M
from 7.14M
Increased by 313.33%
EPS This Year
-0.97
from -0.75
EPS Next Year
-1.05
from -0.97
EPS and Forward PE are based on non-GAAP adjusted numbers.